Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024

Clinical trial NCT07091734 · RECRUITING

Trial details

NCT number: NCT07091734
Sponsor: University of Michigan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lipodystrophy, Partial

Start date: 2025-09-08
Primary completion: 2029-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.